A clinical study to establish in diagnostic criteria and treatment guideline of relapsing polychondritis.

A clinical study to establish in diagnostic criteria and treatment guideline of relapsing polychondritis. - Diagnostic and treatment guideline of relapsing polychondritis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003869

Enrollment

Registered

2010-07-05

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsing polychondritis

Interventions

corticosteroid+methotrexate corticosteroid+ciclosporin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients are going to be treated with an immunosuppresant under corticosteroid therapy.

Exclusion criteria

Exclusion criteria: (1) Patients are thought to require an admission. (2) Patients with severe complications as diabetes mellitus, heart disease, chronic infections or cancers.

Design outcomes

Primary

Measure	Time frame
responce rate in tresatment with corticosteroid and immunosuppressants for 12 months	—

Secondary

Measure	Time frame
OS: overall survival DCR: disease control rate AE: Adverse events	—

Countries

Japan

Contacts

Public ContactJun Shimizu

St. Marianna University School of Medicine Department of Immunology and Medicine

jshimizu@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026